Market Place
Sourcing Support
Palvella Doses 1st Patient in SELVA Phase 3 for Lymphatic Malformations
07 Nov 2024 //
GLOBENEWSWIRE
AgelessRx`s PEARL Trial Links Rapamycin To Healthspan
10 Oct 2024 //
BUSINESSWIRE
Palvella Gets $2.6M FDA Grant For Lymphatic Malformation Trial
03 Oct 2024 //
GLOBENEWSWIRE
Cordis Announces 24-Month Results Confirming Benefits Of SELUTION
18 Jun 2024 //
PR NEWSWIRE
Enforcement Report - Week of May 29, 2024
29 May 2024 //
FDA
Aadi Nab-Sirolimus Tumor Data: Preferential Uptake At Asco 2024
23 May 2024 //
PR NEWSWIRE
Aadi: nab-Sirolimus Combo Data At AACR
09 Apr 2024 //
PR NEWSWIRE
Concept Medical receives USFDA approval for sirolimus drug-coated balloon
01 Apr 2024 //
INDIANPHARMAPOST
Palvella Announces Phase 3 Design of QTORIN™ 3.9% Rapamycin Anhydrous Gel
20 Jul 2023 //
GLOBENEWSWIRE
Plusultra`s Hyftor (Sirolimus) Receives Approval in Europe
08 Jun 2023 //
EMA
HYFTOR 0.2% Coverage Expanded by Medicaid, Including in Key U.S. States
14 Mar 2023 //
PR NEWSWIRE
Palvella Announces Positive Topline Results from Phase 2 Study of QTORIN
09 Mar 2023 //
GLOBENEWSWIRE
Palvella Announces Pipeline Update on QTORINâ 3.9% Rapamycin Anhydrous Gel
21 Feb 2023 //
GLOBENEWSWIRE
Sirolimus Coated Balloon in BTK Treatment makes a bold presence at VEITH 2022
02 Dec 2022 //
PRNEWSWIRE
Mirati & Aadi Partner to Evaluate the Combination of Adagrasib & Nab-sirolimus
12 Oct 2022 //
PRNEWSWIRE
FDA approved HYFTOR is now available in the US
30 Aug 2022 //
PRNEWSWIRE
HYFTOR 0.2% Available Through AllianceRx Walgreens Pharmacy
29 Aug 2022 //
PRNEWSWIRE
Nobelpharma USA Presents Results from Natural History Database of TSC Alliance
09 Aug 2022 //
PRNEWSWIRE
Nobelpharma America Debuts New Product, HYFTOR 0.2%
25 Jul 2022 //
PRNEWSWIRE
Enforcement Report - Week of May 25, 2022
25 May 2022 //
FDA
In a first, FDA approves topical drug for rare disease lesions
06 Apr 2022 //
FIERCEPHARMA
FDA approves Nobelpharma`s HYFTOR™ (sirolimus topical gel) 0.2%
04 Apr 2022 //
PRNEWSWIRE
Aadi Bio Begins Dosing in Phase 2 Trial of nab-Sirolimus in Solid Tumors
31 Mar 2022 //
GLOBENEWSWIRE
Navitor Pharma Announces Janssen Has Acquired Anakuria Therapeutics, Inc.
02 Feb 2022 //
BUSINESSWIRE
Aadi clinches first FDA nod for ultrarare sarcoma drug Fyarro
24 Nov 2021 //
YAHOOFINANCE
Enforcement Report - Week of September 29, 2021
29 Sep 2021 //
FDA
Organ Rejection Drug Rapamycin May Improve Cellular Health
14 Jun 2021 //
NEWSWISE
Alkem Labs`s Generic Sirolimus Receives Approval In US
17 Mar 2021 //
FDA
Glenmark Pharma receives USFDA approval for Sirolimus tablets
19 Oct 2020 //
EXPRESS PHARMA
Timber Announces All CONTROL Study Sites Open and Enrolling Patients
01 Jul 2020 //
GLOBENEWSWIRE
resTORbio Announces Delay of its Ongoing Ph1b/2a trial of RTB101
03 Apr 2020 //
GLOBENEWSWIRE
Palvella`s Commences Ph3 Portion of Phase 2/3 Pivotal Study of PTX-022
13 Nov 2019 //
GLOBENEWSWIRE
Surmodics Sundance catheter a Breakthrough Device in U.S.
29 Oct 2019 //
SEEKINGALPHA
Apotex`s Generic Sirolimus Receives Approval in US
25 Oct 2019 //
FDA
Amneal Pharms LLC’s Generic Sirolimus Receives Approval In The US
19 Oct 2019 //
FDA
Concept Medical racks up breakthrough designations for its drug-coated balloons
30 Aug 2019 //
FIERCE BIOTECH
Orchestra BioMed Appoints Chief Medical Officer
27 Aug 2019 //
CONTRACT PHARMA
Vascular Therapies Completes Enrollment in the ACCESS Study, a US PhIII Trial
19 Aug 2019 //
PR NEWSWIRE
Terumo plans to take Orchestra BioMed`s sirolimus balloon international
14 Jun 2019 //
FIERCE BIOTECH
MedPharm and Palvella expand pachyonychia congenita partnership
19 Feb 2019 //
THEPHARMALETTER
Aadi Bioscience Receives Breakthrough Therapy Designation for TARZIFYX
03 Jan 2019 //
BUSINESSWIRE
Some malaria drugs work against some cancers - boost drug development
16 Nov 2018 //
FIERCE BIOTECH
Bayer’s Americas pharma head takes CEO job at Selecta Biosciences
27 Sep 2018 //
FIERCE BIOTECH
Micell Technologies Announces Expanded Patent Estate
20 Mar 2018 //
PRNEWSWIRE
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points
07 Aug 2017 //
XCONOMY
Kymab’s antibody shows early promise in GvHD prophylaxis
06 Dec 2016 //
PHARMATIMES
Mixed late-stage data for Santen eye drug, but still plots FDA submission
28 Nov 2016 //
FIERCE BIOTECH
Nanoparticles carrying rapamycin help lower immune response to biologic drugs
04 Aug 2016 //
NANO TECH WEB
Selecta Announces Gene Therapy Programs for Two Rare Genetic Metabolic Disorders
19 Jul 2016 //
GLOBENEWSWIRE
Dr Reddy`s recalls 9,330 bottles of Sirolimus tablets in US
14 Jul 2016 //
ECONOMIC TIMES
New preclinical data show a greater anti-tumor activity in renal cell carcinoma
18 Apr 2016 //
PR NEWSWIRE
Pfizer unit to pay $784.6 mln in Medicaid rebate settlement
17 Feb 2016 //
REUTERS
Large pharma companies to see muted growth in FY16
28 Aug 2015 //
BUSINESS STANDARD
Aging As a Disease
18 Jun 2015 //
CORANTE
Wyeth`s Rapamune (sirolimus) Approved in USA For LAM
29 May 2015 //
FDA
PFIZER REPORTS FIRST-QUARTER 2015 RESULTS
28 Apr 2015 //
PFIZER
